Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of 4-dose rabies vaccine regimens versus 5-dose regimen in healthy participants
CTR20244279Phase 3Completed
- Sponsor
- YS Biopharma
- Start
- Nov 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rabies vaccine (vero cell, freeze-dried) in rabies, sponsored by YS Biopharma. Started Nov 2024; status: completed.
02
Drugs
rabies vaccine (vero cell, freeze-dried)
03
Conditions
rabies
Beyond the preview
Go deeper on CTR20244279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244279.